Skip to main content
Published Online:https://doi.org/10.3928/01913913-20150714-01Cited by:1

Abstract

Purpose:

To present the results of ophthalmological examinations in children with muscular dystrophies and highlight the importance of their ophthalmological evaluation.

Methods:

Retrospective analysis of the ophthalmological examination records in 74 children with a type of muscular dystrophy, examined between January 2011 and January 2015, was performed.

Results:

The most common type of muscular dystrophy observed in our patients was Duchenne muscular dystrophy (67.5%), followed by Becker muscular dystrophy (9.4%), myotonic dystrophy (8%), limb-girdle muscular dystrophy (6.7%), merosin-negative muscular dystrophy (4%), and Ullrich muscular dystrophy (4%). Ten cases of Duchenne muscular dystrophy had both macular and retinal pigmentary changes (20%) and 9 had abnormal electroretinographies with decreased photopic and scotopic responses. Ptosis was the most common finding (83.3%). No abnormalities of light reflexes, pupil size, or saccadic and smooth pursuit movements were seen among cases with myotonic dystrophy.

Conclusions:

Ophthalmological problems are commonly seen in children with muscular dystrophies. Simple ophthalmological screening and early intervention can improve their communication skills by way of increasing their visual talents.

[J Pediatr Ophthalmol Strabismus. 2015;52(5):311–316.]

  • 1.Miller NR, Newman NJ, Biousse V, Kerrison JB, eds. Walsh and Hoyt’s Clinical Neuro-Ophthalmology, 6th ed. Philadelphia: Lippincott, Williams & Wilkins; 2005:424–430.

    Google Scholar
  • 2.Andrade FH, Porter JD, Kaminski HJ. Eye muscle sparing by the muscular dystrophies: lessons to be learned?Microsc Res Tech. 2000; 48:192.10.1002/(SICI)1097-0029(20000201/15)48:3/4<192::AID-JEMT7>3.0.CO;2-J

    Crossref MedlineGoogle Scholar
  • 3.Donahue SP, Arthur B, Neely DE, Arnold RW, Silbert D, Ruben JB. Revised guidelines for reporting results from studies of pre-school vision screening. Presented at the AAPOS Annual Meeting; March 27, 2012; San Antonio, Texas.

    Google Scholar
  • 4.Kirschner J. Congenital muscular dystrophies. Handb Clin Neurol. 2013; 113:1377–1385.10.1016/B978-0-444-59565-2.00008-3

    Crossref MedlineGoogle Scholar
  • 5.Kava M, Chitayat D, Blaser S, Ray PN, Vajsar J. Eye and brain abnormalities in congenital muscular dystrophies caused by fukutin-related protein gene (FKRP) mutations. Pediatr Neurol. 2013; 49:374–378.10.1016/j.pediatrneurol.2013.06.022

    Crossref MedlineGoogle Scholar
  • 6.Dobyns WB, Pagon RA, Armstrong D, et al.Diagnostic criteria for Walker-Warburg syndrome. Am J Med Genet. 1989; 32:195–210.10.1002/ajmg.1320320213

    Crossref MedlineGoogle Scholar
  • 7.So K, Shinoda K, Watanabe E, Mashiko T, Mizota A. Vitrectomy for proliferative retinopathy in patient with advanced Duchenne muscular dystrophy. Retin Cases Brief Rep. 2012; 6:142–144.10.1097/ICB.0b013e3182160913

    Crossref MedlineGoogle Scholar
  • 8.Bar S, Barnea E, Levy Z, Neuman S, Yaffe D, Nudel U. A novel product of the Duchenne muscular-dystrophy gene which greatly differs from the known isoforms in its structure and tissue distribution. Biochem J. 1990; 272:557–560.10.1042/bj2720557

    Crossref MedlineGoogle Scholar
  • 9.Louie K, Apte RS, Mori K, Gehlbach P. Severe proliferative retinopathy in a patient with advanced muscular dystrophy. Br J Ophthalmol. 2004; 88:1604–1605.10.1136/bjo.2004.046615

    Crossref MedlineGoogle Scholar
  • 10.Ober MD, Del Priore LV, Tsai J, et al.Diagnostic and therapeutic challenges. Retina. 2006; 26:462–467.10.1097/00006982-200604000-00013

    Crossref MedlineGoogle Scholar
  • 11.Dodge PR, Gamstorp I, Byers RK, Russell P. Myotonic dystrophy in infancy and childhood. Pediatrics. 1965; 35:3–19.

    Crossref MedlineGoogle Scholar
  • 12.Brook JD, McCurrach ME, Harley HG, et al.Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3’ end of transcript encoding a protein kinase family member. Cell. 1992; 68:799–808.10.1016/0092-8674(92)90154-5

    Crossref MedlineGoogle Scholar
  • 13.Harper PS. Myotonic dystrophy. In: , Rimoin DL, Connor JM, Pyeritz RE, Korf BR, eds. Emery and Rimoin’s Principles and Practice of Medical Genetics, 4th ed. Edinburgh: Churchill; 2002:3393–3418.

    Google Scholar
  • 14.Aring E, Ekström AB, Tulinius M, Sjöström A. Ocular motor function in relation to gross motor function in congenital and childhood myotonic dystrophy type 1. Acta Ophthalmol. 2012; 90:369–374.10.1111/j.1755-3768.2010.01956.x

    Crossref MedlineGoogle Scholar
  • 15.Ashizawa T, Hejtmancik JF, Liu J, Ferryman MB, Epstein HF, Koch DD. Diagnostic value of ophthalmic findings in myotonic dystrophy: comparison with risks calculated by haplotype analysis of closely linked restriction fragment length polymorphism. Am J Med Genet. 1992; 42:55–60.10.1002/ajmg.1320420113

    Crossref MedlineGoogle Scholar
  • 16.Koca MR, Horn F, Korth M. Alterations of saccadic eye movements in myotonic dystrophy. Graefes Arch Clin Exp Ophthalmol. 1992; 230:437–441.10.1007/BF00175929

    Crossref MedlineGoogle Scholar
  • 17.Tor Bruggen JP, Bastiaensen LA, Tyssen CC, Gielen G. Disorders of eye movement in myotonic dystrophy. Brain. 1990; 113:463–473.10.1093/brain/113.2.463

    Crossref MedlineGoogle Scholar
  • 18.Bollen E, den Heyer JC, Tolsma MH, Bellari S, Bos JE, Wintzen AR. Eye movements in myotonic dystrophy. Brain. 1992; 115:445–450.10.1093/brain/115.2.445

    Crossref MedlineGoogle Scholar
  • 19.Barnes PR. Clinical and genetic aspects of myotonic dystrophy. Br J Hosp Med. 1993; 50:22–30.

    MedlineGoogle Scholar
  • 20.Bensoussan L, De Saint Jean M, Lozato P, Auzerie O, Ohana L, Baudouin C. Severe bilateral capsulorhexis contraction after cataract surgery in myotonic dystrophy: a case report [article in French]. J Fr Ophtalmol. 2004; 27:479–483.10.1016/S0181-5512(04)96167-0

    Crossref MedlineGoogle Scholar
  • 21.Garrott HM, Walland MJ, O’Day J. Recurrent posterior capsular opacification and capsulorhexis contracture after cataract surgery in myotonic dystrophy. Clin Experiment Ophthalmol. 2004; 32:653–655.10.1111/j.1442-9071.2004.00919.x

    Crossref MedlineGoogle Scholar
  • 22.Kanski JJ. Clinical Ophthalmology. London: Butterworths; 1987;1:8.5.

    Google Scholar
  • 23.Vassilopoulos D, Alevizos B, Spengos M. Cataract and gamma-glutamyl cycle in myotonic dystrophy. Ophthalmologica. 1977; 174:167–169.10.1159/000308595

    Crossref MedlineGoogle Scholar
  • 24.Kimizuka Y, Kiyosawa M, Tamai M, Takase S. Retinal changes in myotonic dystrophy: clinical and follow-up evaluation. Retina. 1993; 13:129–135.10.1097/00006982-199313020-00007

    Crossref MedlineGoogle Scholar

We use cookies on this site to enhance your user experience. For a complete overview of all the cookies used, please see our privacy policy.

×